Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have earned an average rating of “Moderate Buy” from the twelve analysts that are currently covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $13.50.

Several equities research analysts recently commented on AVAH shares. Raymond James Financial lifted their target price on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. UBS Group raised their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. Truist Financial lifted their price target on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, August 24th. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Finally, Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $10.00 to $11.00 in a report on Friday, May 15th.

Aveanna Healthcare Stock Performance

NASDAQ AVAH opened at $13.32 on Monday. The company has a market cap of $2.91 billion, a price-to-earnings ratio of 10.83, a price-to-earnings-growth ratio of 0.84 and a beta of 1.90. Aveanna Healthcare has a twelve month low of $5.93 and a twelve month high of $14.00. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The business’s fifty day moving average is $10.18 and its 200 day moving average is $8.11.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The firm had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. As a group, sell-side analysts expect that Aveanna Healthcare will post 0.75 EPS for the current fiscal year.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Paul R. Vigano sold 2,250,000 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares in the company, valued at $141,632,758. This trade represents a 15.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares in the company, valued at approximately $141,632,758. This represents a 15.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 79,746,745 shares of company stock worth $773,117,091. 5.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently modified their holdings of the company. BlackRock Inc. acquired a new position in Aveanna Healthcare in the second quarter valued at $63,504,000. Vanguard Group Inc. grew its stake in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares during the period. Braidwell LP lifted its stake in Aveanna Healthcare by 39.1% in the second quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock valued at $26,268,000 after buying an additional 861,600 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Aveanna Healthcare by 17.7% during the 4th quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock worth $15,110,000 after buying an additional 278,429 shares in the last quarter. Finally, Nuveen LLC lifted its position in shares of Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after acquiring an additional 905,316 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.